A humanized monoclonal antibody that targets CD19+ B cells becomes the first and only FDA-approved treatment for immunoglobulin G4–related disease, reducing flare risk and glucocorticoid use in clinical trials.
New research reveals 25% tariffs on Canadian pharmaceuticals would impact critical medications, strain supply chains, and potentially increase costs—with 28 drugs having no alternative suppliers.
Individuals with autoimmune arthritides are more likely to experience mood and anxiety disorders—even relative to counterparts with other chronic illnesses—according to a national cohort study.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
A study finds that total hip arthroplasty in patients with minimal radiographic osteoarthritis results in high satisfaction but lower functional outcomes, with only 33% achieving a patient-acceptable symptom state.
An anesthesiologist has been apprehended in Hawaii after allegedly assaulting his spouse at a popular hiking location, resulting in the closure of the Nu'uanu Pali State Wayside.
Proposals include licensure for community health workers, expanded provider roles, and Medicaid coverage adjustments to address staffing gaps and access barriers.
TPT decreased the overall risk of tuberculosis disease in patients with rheumatic diseases, with a 76% risk reduction observed in certain subgroups, researchers reported.